SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-318373
Filing Date
2018-11-05
Accepted
2018-11-05 16:10:41
Documents
3
Period of Report
2018-11-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d645259d8k.htm 8-K 22475
2 EX-4.1 d645259dex41.htm EX-4.1 66121
3 EX-10.1 d645259dex101.htm EX-10.1 470751
  Complete submission text file 0001193125-18-318373.txt   560678
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Filer) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35837 | Film No.: 181160010
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1